Log in to save to my catalogue

Identification of CSF biomarkers by proteomics in Guillam-Barre syndrome

Identification of CSF biomarkers by proteomics in Guillam-Barre syndrome

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A552844503

Identification of CSF biomarkers by proteomics in Guillam-Barre syndrome

About this item

Full title

Identification of CSF biomarkers by proteomics in Guillam-Barre syndrome

Publisher

Spandidos Publications

Journal title

Experimental and therapeutic medicine, 2018-06, Vol.15 (6), p.5177

Language

English

Formats

Publication information

Publisher

Spandidos Publications

More information

Scope and Contents

Contents

The purpose of the present study was to screen for differentially expressed proteins in the cerebrospinal fluid (CSF) of patients with Guillain-Barre syndrome (GBS). The identification of differentially expressed protein can provide new targets for understanding the pathogenic mechanism, early clinical diagnosis, prognosis and for measuring the eff...

Alternative Titles

Full title

Identification of CSF biomarkers by proteomics in Guillam-Barre syndrome

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A552844503

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A552844503

Other Identifiers

ISSN

1792-0981

DOI

10.3892/etm.2018.6117

How to access this item